4/A
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-029113
Chief Commercial Officer acquired 1,032 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2025-05-16 | Grant or award | +1,032 | $2.48 | $2,561 | 25,337 | D |
Loading xslF345X05/wk-form4a_1748984454.xml…